Explore key pharma & medical device industry trends shaping quality management. Learn how AI, regulatory compliance & digital transformation impact life sciences in 2025. https://hubs.li/Q033Sx3n0
SeerPharma’s Post
More Relevant Posts
-
When life sciences met artificial intelligence The pace of AI adoption is quickening in the sector, which includes biopharmaceuticals, digital health, clinical diagnostics and medical devices. https://lnkd.in/eHBmAfrM
To view or add a comment, sign in
-
-
Proud to have attended the webinar titled 'Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development' hosted by FDA. Some of the topics were: Enhancing Clinical Trial Innovation AI in Drug Development Reimagining Clinical Research: The Transformation of Trial Design & Conduct Advanced Manufacturing Technologies (AMT) Designation Program Innovative Approaches to Emerging Threats Grateful for the insights and excited to apply this knowledge in my work. #ContinuousLearning #ProfessionalDevelopment #WebinarCertificate
To view or add a comment, sign in
-
You’re invited! Check out our upcoming sessions on Shimadzu Digital Classrooms: 𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗛𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗧𝗵𝗿𝗼𝘂𝗴𝗵 𝗠𝗦 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀: 𝗪𝗲𝗹𝗹𝗻𝗲𝘀𝘀 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗔𝗻𝗱 𝗖𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗖𝗮𝗿𝗲 | 𝟮𝟮 𝗢𝗰𝘁, 𝗧𝘂𝗲𝘀𝗱𝗮𝘆 Happening tomorrow! Join us to discover how mass spectrometry (MS) technology is transforming advanced healthcare, through its capabilities to enable personalized health monitoring, early disease detection, and critical care management. Whether you are involved in clinical diagnostics or health management, explore with us the expanding influence of MS in today’s healthcare landscape. 𝗥𝗲𝗮𝗹𝗶𝘇𝗶𝗻𝗴 𝗣𝗵𝗮𝗿𝗺𝗮 𝗗𝗫: 𝗗𝗶𝘀𝗰𝗼𝘃𝗲𝗿 𝗦𝗵𝗶𝗺𝗮𝗱𝘇𝘂'𝘀 𝗔𝗜-𝗗𝗿𝗶𝘃𝗲𝗻 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀 𝗔𝗻𝗱 𝗔𝘂𝘁𝗼𝗺𝗮𝘁𝗶𝗼𝗻 | 𝟭𝟮 𝗡𝗼𝘃, 𝗧𝘂𝗲𝘀𝗱𝗮𝘆 Are you ready to transform your pharmaceutical operations? Don’t miss our exclusive session to begin your journey towards Pharma DX. Experience firsthand how Shimadzu’s cutting-edge AI technologies and digital solutions are reshaping the drug development landscape. Learn how our innovative tools effectively streamline workflows, enhance lab efficiency, and maintain strict compliance with regulatory standards. Don’t miss this opportunity to learn about the latest technology and advancements– Register Now: https://lnkd.in/gTb7nafi #Shimadzu #ExcellenceinScience #Pharma #PharmaDX #MassSpectrometry #AdvancedHealthcare
To view or add a comment, sign in
-
-
Accelerate medical writing with GenAI—chosen by 4 of the top 10 global pharma companies. Save up to 70% on CSRs, Protocols, Patient Narratives, and more. Boost accuracy and speed approvals. See how top pharma excel with AI. Click below to download your strategic guide now—limited-time access! https://lnkd.in/gQEUVk9u
To view or add a comment, sign in
-
-
With pharma companies ramping up their GenAI-based experiments, how can commercial, medical and clinical leaders make the right bets? In an interview with Pharma Focus America, our CTO Tarun Mathur shares insights on why GenAI is here to stay, and how it can help pharma companies modernize operations and improve HCP and patient experiences. Read the full story. #FutureReadyHealthcare
To view or add a comment, sign in
-
In an ever-evolving regulatory landscape, trust and compliance are paramount. Dive into our whitepaper where Freyr takes centre stage, detailing our journey to develop GxP-compliant solutions seamlessly integrated with AI capabilities. Discover how Freyr's strategic approach in AI practices ensures compliance and helps builds trustworthy solutions for Pharma, Medical Devices, and Life Sciences industries. Read more: https://lnkd.in/gMdknJgy #RegulatoryCompliance #AIIntegration #TrustInAI #LifeSciences #Pharma #FreyrSolutions Anushta Chandrapalan Praveen Bezawada 𝐉𝐢𝐧 𝐙𝐡𝐚𝐧𝐠 Sumedha Ghuliani
To view or add a comment, sign in
-
-
Happy to share that I have co-authored "Freyr’s Position Paper on Trustworthy AI" alongside my colleagues. In this, we delve into the intricacies of AI-native software development and end-to-end Regulatory compliance in a GxP environment. We explore the critical role of AI from concept to maintenance, ensuring that our solutions are not only innovative but also compliant and reliable. Key Highlights: ✅ AI-native approach. ✅ Validation and compliance with global Regulatory standards. ✅ Commitment to ethical AI with a focus on transparency, fairness, and data privacy. ✅ Continuous risk management and model maintenance for reliability. Read the full paper to gain more insights :) #TrustinAI #AI #ProductManagement
In an ever-evolving regulatory landscape, trust and compliance are paramount. Dive into our whitepaper where Freyr takes centre stage, detailing our journey to develop GxP-compliant solutions seamlessly integrated with AI capabilities. Discover how Freyr's strategic approach in AI practices ensures compliance and helps builds trustworthy solutions for Pharma, Medical Devices, and Life Sciences industries. Read more: https://lnkd.in/gMdknJgy #RegulatoryCompliance #AIIntegration #TrustInAI #LifeSciences #Pharma #FreyrSolutions Anushta Chandrapalan Praveen Bezawada 𝐉𝐢𝐧 𝐙𝐡𝐚𝐧𝐠 Sumedha Ghuliani
To view or add a comment, sign in
-
-
Excited to share OneGlobal Trinity M Consulting recent article post about “Pioneering Excellence in the Medical Device, Pharmaceutical, and Biotechnology Market” in MedTech Dive Newsletter, April 22, 2024 release. Read more below. #trinitymconsulting #globalconsulting #medtech #medicaldevices
To view or add a comment, sign in
-
Here’s a very insightful interview with my excellent colleague Tarun Mathur with Pharma Focus America, where he shares how Generative AI (GenAI) is transforming the pharma industry. GenAI presents various opportunities in modernizing operations, enhancing HCP and patient experiences, and guiding commercial, medical, and clinical leaders toward smarter decision-making. Tarun highlights the long-term potential of GenAI in driving innovation and improving healthcare outcomes. If you're curious about how GenAI is shaping the future of healthcare, this is a must-read! #FutureReadyHealthcare #GenAI #PharmaInnovation #HealthcareTransformation Indegene
With pharma companies ramping up their GenAI-based experiments, how can commercial, medical and clinical leaders make the right bets? In an interview with Pharma Focus America, our CTO Tarun Mathur shares insights on why GenAI is here to stay, and how it can help pharma companies modernize operations and improve HCP and patient experiences. Read the full story. #FutureReadyHealthcare
To view or add a comment, sign in